세계의 호기 분석기 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Breath Analyzers was estimated to be worth US$ 263 million in 2024 and is forecast to a readjusted size of US$ 566 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Breath Analyzers cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Breath Molecular Diagnosis is a medical diagnosis based on the detection of the molecular composition of exhaled breath, also referred to as Breath Diagnosis or Breath Test. Medical diagnosis based on the detection of exhaled flow pressure is called Pulmonary Function Test, which is also a type of exhaled test or exhaled diagnosis. To avoid confusion, the issuer mainly uses the name "exhaled molecular diagnosis", but sometimes for the sake of simplicity and consistency with the name of the outside world, the name "exhaled diagnosis" or "exhaled test" is also used. Exhaled molecular diagnosis is an emerging in vitro diagnostic (IVD) technology. Generally speaking, in vitro diagnosis requires the use of diagnostic reagents and equipment to analyze samples such as blood or urine. Sampling is performed first and then analysis. Cells, microorganisms and biochemical molecules can be analyzed. It is mainly used for the diagnosis of blood circulation or systemic diseases. Exhaled molecular diagnosis does not require diagnostic reagents, and sampling and analysis can be performed at the same time. It analyzes gas molecules produced by cell and microbial metabolism, which is particularly suitable for the diagnosis of respiratory and digestive related diseases. The role of exhaled breath molecular diagnosis is complementary to that of blood tests and imaging diagnosis. Like existing in vitro diagnostics, exhaled breath molecular diagnosis is also divided into two categories: professional laboratories and point-of-care diagnostics (POCT). Professional laboratories use laboratory analytical equipment such as gas chromatography, mass spectrometry and spectroscopy to perform exhaled breath analysis on patients' exhaled breath bags or gas collection tubes; due to the lack of exhaled breath sensor products, Europe and the United States currently provide analytical services for H2, CH4 and VOC (volatile organic compounds) exhaled breath metabolomics through professional laboratories. Point-of-care diagnostics (POCT) use exhaled breath detection sensors, which integrate sampling and analysis. Patients only need a few seconds to sample their breath, and the instrument only needs tens of seconds to analyze the results. In summary, the issuer belongs to the POCT sub-industry in the emerging IVD field. Exhaled breath molecular diagnostic equipment is classified as a low-risk medical device by European and American drug regulatory authorities. The U.S. FDA believes that exhaled breath testing will affect medical diagnostic results. As a Class II medical device, it only tests and certifies the performance of exhaled breath testing. The EU regulates it as a special Class I medical device similar to a sphygmomanometer, which only requires self-testing or third-party laboratory testing according to EN standards. Therefore, exhaled breath molecular diagnostic equipment was first launched in Europe, and there are many of them now. China currently regulates exhaled breath molecular diagnostic equipment as Class II medical devices, and registration takes a long time. At present, most medical devices related to exhaled breath molecular diagnostic technology are in the market cultivation or introduction stage, requiring a large number of clinical trials, certification and registration.

POCT based on exhaled breath molecular diagnosis can provide detection items that blood test POCT lacks, such as detection of airway inflammation and gastrointestinal flora metabolic disorders. Moreover, POCT based on exhaled breath molecular diagnosis does not require blood drawing, and has the characteristics of non-invasive, instant, and biopsy. It can be used to make up for the shortcomings of in vitro diagnosis such as blood tests and imaging, avoid the risks of invasive in vivo diagnosis, and is more suitable for the use of common diseases and chronic diseases in hospitals, grassroots physical examinations, and family self-examination. In recent years, exhaled breath molecular diagnosis technology has been increasingly valued by domestic and foreign governments, research and development institutions, and related medical organizations. Various organizations and institutions have formulated relevant policies, development plans, and standard guidelines to jointly promote the rapid development of clinical technology for exhaled breath molecular diagnosis.

Exhaled breath molecular diagnosis or breath testing belongs to the emerging field of POCT technology. At present, the Helicobacter pylori breath test with the largest market size has a market history of less than 25 years, and the development of the inflammatory breath test product with the greatest market potential has only been 10 years, while breath testing technologies such as gastrointestinal flora metabolic disorders are still in the market cultivation stage. In addition, breath detection technologies such as breath NH3, H2S, VOC (volatile organic compounds), breath metabolomics and olfactory artificial intelligence (electronic nose) are still in clinical trials or waiting for drug regulatory certification and approval.

In the past 30 years, with the gradual development of related technologies including breath detection abroad, the rapid growth of the domestic economy and the continuous development of the medical and health industry have provided a broad market space for the widespread application of this technology in China. At the same time, the development of domestic breath detection technology is almost synchronized with that of foreign countries, covering almost all areas of foreign breath detection, including the research of breath metabolomics and olfactory artificial intelligence, and many technologies are even ahead of foreign countries. It is one of the few emerging technology fields that may form a global leading breath detection in China.

With the continuous advancement of the construction of the PCCM system, the demand for breath analysis products in secondary and tertiary hospitals will further expand. Portable instrument products, handheld instrument products and other products for primary hospitals and home terminals are constantly being developed, and product application scenarios and usage needs will be further expanded.

With the development of science and technology and artificial intelligence, future breathalyzers will be more intelligent and automated, with functions such as automatic identification, data analysis and report generation, reducing human intervention and improving diagnostic accuracy and efficiency.

This report aims to provide a comprehensive presentation of the global market for Breath Analyzers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Breath Analyzers by region & country, by Type, and by Application.

The Breath Analyzers market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breath Analyzers.

Market Segmentation

By Company

• NIOX Group plc
• Sunvou Medical Electronics Co
• Headway
• Richen Holding
• Meridian Bioscience
• CAPNIA, Inc.
• Kibion
• Otsuka Electronics
• LEYI BIOLOGY
• Shenzhen Breax
• Eco Physics AG
• QuinTron Instrument Company
• Beijing Wanliandaxinke Instruments Co
• SIMES SIKMA
• Beijing Safe Heart Technology
• e-LinkCare Meditech Co
• ChromX Health
• Huiyuen Tech
• Shanghai Topfeel Medtech Co., Ltd.
• Yutong Yiliao
• RUNSKY
• Yuwell
• ETEST Medical
• SEEKYA

Segment by Type

• C13 Type
• NO Type
• H2/CO Type
• VOCs Type

Segment by Application

• Hospital
• Clinic
• Physical Examination Center
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Breath Analyzers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Breath Analyzers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Breath Analyzers in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Breath Analyzers Product Introduction
• 1.2 Global Breath Analyzers Market Size Forecast
  • 1.2.1 Global Breath Analyzers Sales Value (2020-2031)
  • 1.2.2 Global Breath Analyzers Sales Volume (2020-2031)
  • 1.2.3 Global Breath Analyzers Sales Price (2020-2031)
• 1.3 Breath Analyzers Market Trends & Drivers
  • 1.3.1 Breath Analyzers Industry Trends
  • 1.3.2 Breath Analyzers Market Drivers & Opportunity
  • 1.3.3 Breath Analyzers Market Challenges
  • 1.3.4 Breath Analyzers Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Breath Analyzers Players Revenue Ranking (2024)
• 2.2 Global Breath Analyzers Revenue by Company (2020-2025)
• 2.3 Global Breath Analyzers Players Sales Volume Ranking (2024)
• 2.4 Global Breath Analyzers Sales Volume by Company Players (2020-2025)
• 2.5 Global Breath Analyzers Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Breath Analyzers Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Breath Analyzers Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Breath Analyzers
• 2.9 Breath Analyzers Market Competitive Analysis
  • 2.9.1 Breath Analyzers Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Breath Analyzers Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breath Analyzers as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 C13 Type
  • 3.1.2 NO Type
  • 3.1.3 H2/CO Type
  • 3.1.4 VOCs Type
• 3.2 Global Breath Analyzers Sales Value by Type
  • 3.2.1 Global Breath Analyzers Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Breath Analyzers Sales Value, by Type (2020-2031)
  • 3.2.3 Global Breath Analyzers Sales Value, by Type (%) (2020-2031)
• 3.3 Global Breath Analyzers Sales Volume by Type
  • 3.3.1 Global Breath Analyzers Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Breath Analyzers Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Breath Analyzers Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Breath Analyzers Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Physical Examination Center
  • 4.1.4 Other
• 4.2 Global Breath Analyzers Sales Value by Application
  • 4.2.1 Global Breath Analyzers Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Breath Analyzers Sales Value, by Application (2020-2031)
  • 4.2.3 Global Breath Analyzers Sales Value, by Application (%) (2020-2031)
• 4.3 Global Breath Analyzers Sales Volume by Application
  • 4.3.1 Global Breath Analyzers Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Breath Analyzers Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Breath Analyzers Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Breath Analyzers Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Breath Analyzers Sales Value by Region
  • 5.1.1 Global Breath Analyzers Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Breath Analyzers Sales Value by Region (2020-2025)
  • 5.1.3 Global Breath Analyzers Sales Value by Region (2026-2031)
  • 5.1.4 Global Breath Analyzers Sales Value by Region (%), (2020-2031)
• 5.2 Global Breath Analyzers Sales Volume by Region
  • 5.2.1 Global Breath Analyzers Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Breath Analyzers Sales Volume by Region (2020-2025)
  • 5.2.3 Global Breath Analyzers Sales Volume by Region (2026-2031)
  • 5.2.4 Global Breath Analyzers Sales Volume by Region (%), (2020-2031)
• 5.3 Global Breath Analyzers Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Breath Analyzers Sales Value, 2020-2031
  • 5.4.2 North America Breath Analyzers Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Breath Analyzers Sales Value, 2020-2031
  • 5.5.2 Europe Breath Analyzers Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Breath Analyzers Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Breath Analyzers Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Breath Analyzers Sales Value, 2020-2031
  • 5.7.2 South America Breath Analyzers Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Breath Analyzers Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Breath Analyzers Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Breath Analyzers Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Breath Analyzers Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Breath Analyzers Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Breath Analyzers Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Breath Analyzers Sales Value, 2020-2031
  • 6.3.2 United States Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Breath Analyzers Sales Value, 2020-2031
  • 6.4.2 Europe Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Breath Analyzers Sales Value, 2020-2031
  • 6.5.2 China Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Breath Analyzers Sales Value, 2020-2031
  • 6.6.2 Japan Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Breath Analyzers Sales Value, 2020-2031
  • 6.7.2 South Korea Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Breath Analyzers Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Breath Analyzers Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Breath Analyzers Sales Value, 2020-2031
  • 6.9.2 India Breath Analyzers Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Breath Analyzers Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 NIOX Group plc
  • 7.1.1 NIOX Group plc Company Information
  • 7.1.2 NIOX Group plc Introduction and Business Overview
  • 7.1.3 NIOX Group plc Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 NIOX Group plc Breath Analyzers Product Offerings
  • 7.1.5 NIOX Group plc Recent Development
• 7.2 Sunvou Medical Electronics Co
  • 7.2.1 Sunvou Medical Electronics Co Company Information
  • 7.2.2 Sunvou Medical Electronics Co Introduction and Business Overview
  • 7.2.3 Sunvou Medical Electronics Co Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Sunvou Medical Electronics Co Breath Analyzers Product Offerings
  • 7.2.5 Sunvou Medical Electronics Co Recent Development
• 7.3 Headway
  • 7.3.1 Headway Company Information
  • 7.3.2 Headway Introduction and Business Overview
  • 7.3.3 Headway Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Headway Breath Analyzers Product Offerings
  • 7.3.5 Headway Recent Development
• 7.4 Richen Holding
  • 7.4.1 Richen Holding Company Information
  • 7.4.2 Richen Holding Introduction and Business Overview
  • 7.4.3 Richen Holding Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Richen Holding Breath Analyzers Product Offerings
  • 7.4.5 Richen Holding Recent Development
• 7.5 Meridian Bioscience
  • 7.5.1 Meridian Bioscience Company Information
  • 7.5.2 Meridian Bioscience Introduction and Business Overview
  • 7.5.3 Meridian Bioscience Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Meridian Bioscience Breath Analyzers Product Offerings
  • 7.5.5 Meridian Bioscience Recent Development
• 7.6 CAPNIA, Inc.
  • 7.6.1 CAPNIA, Inc. Company Information
  • 7.6.2 CAPNIA, Inc. Introduction and Business Overview
  • 7.6.3 CAPNIA, Inc. Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 CAPNIA, Inc. Breath Analyzers Product Offerings
  • 7.6.5 CAPNIA, Inc. Recent Development
• 7.7 Kibion
  • 7.7.1 Kibion Company Information
  • 7.7.2 Kibion Introduction and Business Overview
  • 7.7.3 Kibion Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Kibion Breath Analyzers Product Offerings
  • 7.7.5 Kibion Recent Development
• 7.8 Otsuka Electronics
  • 7.8.1 Otsuka Electronics Company Information
  • 7.8.2 Otsuka Electronics Introduction and Business Overview
  • 7.8.3 Otsuka Electronics Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Otsuka Electronics Breath Analyzers Product Offerings
  • 7.8.5 Otsuka Electronics Recent Development
• 7.9 LEYI BIOLOGY
  • 7.9.1 LEYI BIOLOGY Company Information
  • 7.9.2 LEYI BIOLOGY Introduction and Business Overview
  • 7.9.3 LEYI BIOLOGY Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 LEYI BIOLOGY Breath Analyzers Product Offerings
  • 7.9.5 LEYI BIOLOGY Recent Development
• 7.10 Shenzhen Breax
  • 7.10.1 Shenzhen Breax Company Information
  • 7.10.2 Shenzhen Breax Introduction and Business Overview
  • 7.10.3 Shenzhen Breax Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Shenzhen Breax Breath Analyzers Product Offerings
  • 7.10.5 Shenzhen Breax Recent Development
• 7.11 Eco Physics AG
  • 7.11.1 Eco Physics AG Company Information
  • 7.11.2 Eco Physics AG Introduction and Business Overview
  • 7.11.3 Eco Physics AG Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Eco Physics AG Breath Analyzers Product Offerings
  • 7.11.5 Eco Physics AG Recent Development
• 7.12 QuinTron Instrument Company
  • 7.12.1 QuinTron Instrument Company Company Information
  • 7.12.2 QuinTron Instrument Company Introduction and Business Overview
  • 7.12.3 QuinTron Instrument Company Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 QuinTron Instrument Company Breath Analyzers Product Offerings
  • 7.12.5 QuinTron Instrument Company Recent Development
• 7.13 Beijing Wanliandaxinke Instruments Co
  • 7.13.1 Beijing Wanliandaxinke Instruments Co Company Information
  • 7.13.2 Beijing Wanliandaxinke Instruments Co Introduction and Business Overview
  • 7.13.3 Beijing Wanliandaxinke Instruments Co Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Beijing Wanliandaxinke Instruments Co Breath Analyzers Product Offerings
  • 7.13.5 Beijing Wanliandaxinke Instruments Co Recent Development
• 7.14 SIMES SIKMA
  • 7.14.1 SIMES SIKMA Company Information
  • 7.14.2 SIMES SIKMA Introduction and Business Overview
  • 7.14.3 SIMES SIKMA Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 SIMES SIKMA Breath Analyzers Product Offerings
  • 7.14.5 SIMES SIKMA Recent Development
• 7.15 Beijing Safe Heart Technology
  • 7.15.1 Beijing Safe Heart Technology Company Information
  • 7.15.2 Beijing Safe Heart Technology Introduction and Business Overview
  • 7.15.3 Beijing Safe Heart Technology Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Beijing Safe Heart Technology Breath Analyzers Product Offerings
  • 7.15.5 Beijing Safe Heart Technology Recent Development
• 7.16 e-LinkCare Meditech Co
  • 7.16.1 e-LinkCare Meditech Co Company Information
  • 7.16.2 e-LinkCare Meditech Co Introduction and Business Overview
  • 7.16.3 e-LinkCare Meditech Co Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 e-LinkCare Meditech Co Breath Analyzers Product Offerings
  • 7.16.5 e-LinkCare Meditech Co Recent Development
• 7.17 ChromX Health
  • 7.17.1 ChromX Health Company Information
  • 7.17.2 ChromX Health Introduction and Business Overview
  • 7.17.3 ChromX Health Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 ChromX Health Breath Analyzers Product Offerings
  • 7.17.5 ChromX Health Recent Development
• 7.18 Huiyuen Tech
  • 7.18.1 Huiyuen Tech Company Information
  • 7.18.2 Huiyuen Tech Introduction and Business Overview
  • 7.18.3 Huiyuen Tech Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Huiyuen Tech Breath Analyzers Product Offerings
  • 7.18.5 Huiyuen Tech Recent Development
• 7.19 Shanghai Topfeel Medtech Co., Ltd.
  • 7.19.1 Shanghai Topfeel Medtech Co., Ltd. Company Information
  • 7.19.2 Shanghai Topfeel Medtech Co., Ltd. Introduction and Business Overview
  • 7.19.3 Shanghai Topfeel Medtech Co., Ltd. Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Shanghai Topfeel Medtech Co., Ltd. Breath Analyzers Product Offerings
  • 7.19.5 Shanghai Topfeel Medtech Co., Ltd. Recent Development
• 7.20 Yutong Yiliao
  • 7.20.1 Yutong Yiliao Company Information
  • 7.20.2 Yutong Yiliao Introduction and Business Overview
  • 7.20.3 Yutong Yiliao Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Yutong Yiliao Breath Analyzers Product Offerings
  • 7.20.5 Yutong Yiliao Recent Development
• 7.21 RUNSKY
  • 7.21.1 RUNSKY Company Information
  • 7.21.2 RUNSKY Introduction and Business Overview
  • 7.21.3 RUNSKY Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 RUNSKY Breath Analyzers Product Offerings
  • 7.21.5 RUNSKY Recent Development
• 7.22 Yuwell
  • 7.22.1 Yuwell Company Information
  • 7.22.2 Yuwell Introduction and Business Overview
  • 7.22.3 Yuwell Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.22.4 Yuwell Breath Analyzers Product Offerings
  • 7.22.5 Yuwell Recent Development
• 7.23 ETEST Medical
  • 7.23.1 ETEST Medical Company Information
  • 7.23.2 ETEST Medical Introduction and Business Overview
  • 7.23.3 ETEST Medical Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.23.4 ETEST Medical Breath Analyzers Product Offerings
  • 7.23.5 ETEST Medical Recent Development
• 7.24 SEEKYA
  • 7.24.1 SEEKYA Company Information
  • 7.24.2 SEEKYA Introduction and Business Overview
  • 7.24.3 SEEKYA Breath Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.24.4 SEEKYA Breath Analyzers Product Offerings
  • 7.24.5 SEEKYA Recent Development

8 Industry Chain Analysis

• 8.1 Breath Analyzers Industrial Chain
• 8.2 Breath Analyzers Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Breath Analyzers Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Breath Analyzers Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer